| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| DXCM | DEXCOM INC | EVP Chief Commercial Officer | $8.96M | Mar 12, 2024 | ||
| ALT | Altimmune, Inc. | Director | Sep 25, 2025 | |||
| CLDX | Celldex Therapeutics, Inc. | SVP & Chief Commercial Officer | Nov 10, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|